Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01143896 · ClinicalTrials.gov registry record · NA
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
A NA study of Depression and Hepatitis C, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 309
- Enrollment target
- 4
- Study locations
NCT01143896: Completed NA study of Depression and Hepatitis C, sponsored by VA Office of Research and Development.
NCT01143896 is a NA study of Depression and Hepatitis C that has completed, run by VA Office of Research and Development. The registered enrollment target is 309 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (61% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01143896, a NA study of Depression and Hepatitis C, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 309 participants
- Enrollment target
- 4
- Study locations
Study Summary
Chronic infection with hepatitis C (CHC) is a common and expensive condition, and it disproportionately affects Veterans. Treatment with antiviral therapy reduces liver disease progression and improves health related quality of life. However, \~70% of Veterans with CHC are considered ineligible for antiviral treatment. Most of these patients are excluded due to the presence of co-existing depression and substance use. The proposed project will adapt and adopt an evidence-based collaborative depression care model in CHC clinics. By removing the leading contraindication for antiviral treatment, this project will potentially yield benefits that go far beyond the obvious quality of life benefit from antidepressant therapy itself.
Primary Outcome
Antiviral treatment initiation was measured dichotomously by assigning a value of 1 if the patient received at least one prescription of interferon within 12 months of enrollment, and a value of 0 otherwise.
Conditions Studied
Interventions
- OTHER Depression collaborative care model
Study Locations (4)
Arkansas
- Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock - Little Rock
California
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Missouri
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO - St Louis
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-11 |
| Phase | NA |
What the finished NCT01143896 record still lists
NCT01143896 is an interventional study that assigns participants to a tested intervention. The registered 309 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (61% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Depression collaborative care model is the first listed.
NCT01143896 reports a single indexed study location in Arkansas, California, Missouri.
Frequently Asked Questions
What is clinical trial NCT01143896 about?
NCT01143896 is a clinical study titled "Hepatitis C Translating Initiatives for Depression Into Effective Solutions". Chronic infection with hepatitis C (CHC) is a common and expensive condition, and it disproportionately affects Veterans. Treatment with antiviral therapy reduces liver disease progression and improves health related quality of life. However, \~70% of Veterans with CHC are considered ineligible for ...
What is the current status of trial NCT01143896?
This trial is currently completed. It is a NA study. The enrollment target is 309 participants. The study started on 2012-02. Estimated completion is 2015-11.
What conditions does trial NCT01143896 study?
This clinical trial studies the following conditions: Depression, Hepatitis C.
What interventions are being tested in trial NCT01143896?
The interventions under investigation include: Depression collaborative care model (OTHER).
Who is sponsoring clinical trial NCT01143896?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01143896 being conducted?
This trial has 4 study locations across Arkansas, California, Missouri, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01143896's enrollment target sits among peer trials
309 135th of 679 higher than 545 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03011684 · 309 participants · Phase 3
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
- NCT06915233 · 309 participants · Phase 3
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia